glp 1 for teenagers Use of GLP-1 weight-loss drugs soars among teens, young adults As conversations around GLP-1 medications

Maintaining open communication with your healthcare team allows for adjustments to optimize both symptom management and therapeutic outcomes

A review of the effects of glucagon-like Peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans

The link between creatine and cancer is also quite interesting

Open check-ins: Share honestly with your providers about how food and body thoughts are shifting

Main outcome measures and results: Primary outcome measures included 12-month changes from baseline in claudication distance and maximal walking distance, as assessed by treadmill